Christian Gerecke

The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming

Sophia M. Hochrein, Hao Wu, Miriam Eckstein et al. · Cell Metabolism · 2022 · 216 citations · Full text

Signal Transduction, Cell Signaling, T-regulatory Cell +11

Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma

Thorsten Stühmer, Manik Chatterjee, Martin Hildebrandt et al. · Blood · 2005 · 177 citations · Full text

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma

E. K., Uta Bertsch, Jan Dürig et al. · Leukemia · 2015 · 140 citations

Hematological Malignancy, Oncology, Versus Bortezomib +7

Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)

Stefan Knop, Christian Gerecke, Peter Liebisch et al. · Blood · 2009 · 121 citations

The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma

Manik Chatterjee, Christoph Rancsó, Thorsten Stühmer et al. · Blood · 2007 · 108 citations